Both C3 and C4 have emerged as constituents of tumor-promoting inflammation, implicated in immune modulation by activating protumorigenic neutrophils and tumor-associated macrophages as well as inducing PI3K/AKT-dependent tumor cell proliferation and epithelial-mesenchymal transition [42,43]. The gene discussed is C3; the disease is neoplasm.